Plain-English translation of NCT07687186 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a medication called Qishen Yiqi Dripping Pills to see if it can help people with chronic heart failure that developed from coronary heart disease. About 636 people will either receive this medication or a placebo (inactive treatment) three times a day for several months. The study will measure whether this treatment improves heart function and is safe.
Many people with heart failure don't fully recover with standard heart medications alone. Researchers want to know whether this herbal treatment, which has roots in traditional Chinese medicine, can offer additional benefit alongside standard care.
You likely qualify if…
You likely don't qualify if…
You would take either the medication or a placebo three times daily by mouth, half an hour after meals. You would continue taking your regular heart medications as prescribed. You'll have regular clinic visits to check your heart function, blood pressure, and overall health. The study will track how you feel and measure whether your heart is pumping better over time.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
China